Cantor Virtual Brain Week 2

Cantor Virtual Brain Week 2


The Cantor Biotech Equity Research Team hosted its 2023 Virtual Brain Week 2 from Tuesday, December 12, to Friday, December 15, 2023. Cantor’s Virtual Brain Week 2 featured interactive discussions, fireside chats, and panel presentations focusing on Neuro-Innovators that develop and commercialize medicines for high unmet need indications in the Neurology & Psychiatry industries.

  • Summarized of “lessons learned” following Fall/Winter ’23 clinical conferences, including:
    • CTAD
    • AES
    • SFN
    • ACNP
    • WorldSleep
    • WorldMuscle
    • ObesityWeek
  • Reviewed clinical impact and broadening commercial prospects of recently approved rare disease therapeutics
    • Outlined key drivers of adoption for ACAD’s DAYBUE (Rett Syndrome) and RETA’s SKYCLARYS (Friedreich’s Ataxia)
  • Discussed emerging paradigm shifters (e.g., LEQEMBI) that paves the way for regulatory success and bolstered confidence in regulatory process and Neuro-Innovation
  • KOL panels on key topics in Neurology/Psychiatry/Endocrinology
  • Previewed impactful newsflow/data that may set the stage for alpha generation by investing in practice-change neuro/psych therapies in 2024
  • Fireside chats with senior management of selected Neuro-Innovator companies
  • Virtual NDR meetings with selected Neuro-Innovator companies by request

Cantor Virtual Brain Week

Cantor Technology Conference 2023

Global Healthcare Conference 2023

Cantor Fitzgerald's Crypto & Disruptive Finance Conference

Cantor Oncology & HemOnc Conference

Cantor Medical and Aesthetic Dermatology & Ophthalmology Conference

Cantor Neurology & Psychiatry Conference

Cantor Fitzgerald's Cell and Genetic Medicines Conference

PropTech Conference 2022

Cantor Fitzgerald Technology ESG Conference 2022